This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Akhtar AM, Arif MA, Kanwal S, Majeed S. Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan. J Pak Med Assoc. 2016 Aug;66(8):989–993.AkhtarAMArifMAKanwalSMajeedS.Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan. J Pak Med Assoc.2016Aug;66(8):989–993.Search in Google Scholar
Bhattacherjee S, Datta S. Primary multi drug resistant extra-pulmonary tuberculosis presenting as cervical lymphadenitis. J Glob Infect Dis. 2014;6(2):91–92. https://doi.org/10.4103/0974-777X.132066BhattacherjeeSDattaS.Primary multi drug resistant extra-pulmonary tuberculosis presenting as cervical lymphadenitis. J Glob Infect Dis.2014;6(2):91–92. https://doi.org/10.4103/0974-777X.13206610.4103/0974-777X.132066404905024926174Search in Google Scholar
Ejaz M, Siddiqui AR, Rafiq Y, Malik F, Channa A, Mangi R, Habib F, Hasan R. Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans R Soc Trop Med Hyg. 2010 Aug;104(8):511–517. https://doi.org/10.1016/j.trstmh.2010.03.005EjazMSiddiquiARRafiqYMalikFChannaAMangiRHabibFHasanR.Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans R Soc Trop Med Hyg.2010Aug;104(8):511–517. https://doi.org/10.1016/j.trstmh.2010.03.00510.1016/j.trstmh.2010.03.00520427065Search in Google Scholar
GLI. Mycobacteriology Laboratory Manual [Internet]. Global Laboratory Initiative a Working Group of the Stop TB Partnership; 2014 [cited 2019 Oct 3]. Available from http://www.who.int/tb/laboratory/mycobacteriology-laboratory-manual.pdfGLI. Mycobacteriology Laboratory Manual [Internet]. Global Laboratory Initiative a Working Group of the Stop TB Partnership; 2014[cited 2019 Oct 3]. Available from http://www.who.int/tb/laboratory/mycobacteriology-laboratory-manual.pdfSearch in Google Scholar
Grange JM, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Promot Health. 2002 Jun;122(2):78–81. https://doi.org/10.1177/146642400212200206GrangeJMZumlaA.The global emergency of tuberculosis: what is the cause?J R Soc Promot Health.2002Jun;122(2):78–81. https://doi.org/10.1177/14664240021220020610.1177/14664240021220020612134771Search in Google Scholar
Hoa NB, Nhung NV, Khanh PH, Hai NV, Quyen BTT. Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam. BMC Res Notes. 2015 Dec;8(1):809. https://doi.org/10.1186/s13104-015-1806-4HoaNBNhungNVKhanhPHHaiNVQuyenBTT.Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam. BMC Res Notes.2015Dec;8(1):809. https://doi.org/10.1186/s13104-015-1806-410.1186/s13104-015-1806-4468736026695761Search in Google Scholar
Javaid A, Hasan R, Zafar A, Ghafoor A, Pathan AJ, Rab A, Sadiq A, Akram CM, Burki I, Shah K, et al. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis. 2008 Mar;12(3):326–331.JavaidAHasanRZafarAGhafoorAPathanAJRabASadiqAAkramCMBurkiIShahK, Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis.2008Mar;12(3):326–331.Search in Google Scholar
Khan MT, Malik SI, Ali S, Sheed Khan A, Nadeem T, Zeb MT, Masood N, Afzal MT. Prevalence of pyrazinamide resistance in Khyber Pakhtunkhwa, Pakistan. Microb Drug Resist. 2018 Nov; 24(9):1417–1421. https://doi.org/10.1089/mdr.2017.0234KhanMTMalikSIAliSSheed KhanANadeemTZebMTMasoodNAfzalMT.Prevalence of pyrazinamide resistance in Khyber Pakhtunkhwa, Pakistan. Microb Drug Resist.2018Nov; 24(9):1417–1421. https://doi.org/10.1089/mdr.2017.023410.1089/mdr.2017.023429584579Search in Google Scholar
Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med. 2009 Dec 22;6(12):e1000199. https://doi.org/10.1371/journal.pmed.1000199NeyrollesOQuintana-MurciL.Sexual inequality in tuberculosis. PLoS Med.2009Dec 22;6(12):e1000199. https://doi.org/10.1371/journal.pmed.100019910.1371/journal.pmed.1000199278812920027210Search in Google Scholar
NTP. Vision 2020 – National TB Control Strategic Plan [Internet]. Islamabad (Pakistan): National TB Control Program; 2014 [cited 2019 Oct 3]. Available from http://www.ntp.gov.pk/uploads/Vision_2020_National_Strategic_Plan.pdfNTP. Vision 2020 – National TB Control Strategic Plan [Internet]. Islamabad (Pakistan): National TB Control Program; 2014[cited 2019 Oct 3]. Available from http://www.ntp.gov.pk/uploads/Vision_2020_National_Strategic_Plan.pdfSearch in Google Scholar
NTP. National Guidelines for Diagnosis and Management of Tuberculosis in Pakistan [Internet]. Islamabad (Pakistan): National TB Control Program; 2015 [cited 2019 Oct 3]. Available from http://ntp.gov.pk/uploads/national_guideline_on_tb_case_management_rev_jan_2015.pdfNTP. National Guidelines for Diagnosis and Management of Tuberculosis in Pakistan [Internet]. Islamabad (Pakistan): National TB Control Program; 2015[cited 2019 Oct 3]. Available from http://ntp.gov.pk/uploads/national_guideline_on_tb_case_management_rev_jan_2015.pdfSearch in Google Scholar
O’Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, Padayatchi N. Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. Emerg Infect Dis. 2011 Oct;17(10):1942–1945. https://doi.org/10.3201/eid1710.110105O’DonnellMRZelnickJWernerLMasterILovedayMHorsburghCRPadayatchiN.Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. Emerg Infect Dis.2011Oct;17(10):1942–1945. https://doi.org/10.3201/eid1710.11010510.3201/eid1710.110105331066722000378Search in Google Scholar
Wattal C, Raveendran R, Oberoi JK. Multidrug-resistant pulmonary and extrapulmonary tuberculosis: A 13 years retrospective hospital-based analysis. Indian J Med Res. 2015;142(5):575–582. https://doi.org/10.4103/0971-5916.171285WattalCRaveendranROberoiJK.Multidrug-resistant pulmonary and extrapulmonary tuberculosis: A 13 years retrospective hospital-based analysis. Indian J Med Res.2015;142(5):575–582. https://doi.org/10.4103/0971-5916.17128510.4103/0971-5916.171285474334526658593Search in Google Scholar
Tahseen S, Qadeer E, Khanzada FM, Rizvi AH, Dean A, Van Deun A, Zignol M. Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan. Int J Tuberc Lung Dis. 2016 Apr 01;20(4):448–455. https://doi.org/10.5588/ijtld.15.0645TahseenSQadeerEKhanzadaFMRizviAHDeanAVan DeunAZignolM.Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan. Int J Tuberc Lung Dis.2016Apr 01;20(4):448–455. https://doi.org/10.5588/ijtld.15.064510.5588/ijtld.15.064526970152Search in Google Scholar
Ullah I, Javaid A, Tahir Z, Ullah O, Shah AA, Hasan F, Ayub N. Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS One. 2016 Jan 25;11(1):e0147529. https://doi.org/10.1371/journal.pone.0147529UllahIJavaidATahirZUllahOShahAAHasanFAyubN.Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS One.2016Jan 25;11(1):e0147529. https://doi.org/10.1371/journal.pone.014752910.1371/journal.pone.0147529472658726809127Search in Google Scholar
Ullah I, Shah AA, Basit A, Ali M, Khan A, Ullah U, Ihtesham M, Mehreen S, Mughal A, Javaid A. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infect Dis. 2016 Dec;16(1):413. https://doi.org/10.1186/s12879-016-1745-2UllahIShahAABasitAAliMKhanAUllahUIhteshamMMehreenSMughalAJavaidA.Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infect Dis.2016Dec;16(1):413. https://doi.org/10.1186/s12879-016-1745-210.1186/s12879-016-1745-2498304727519406Search in Google Scholar
WHO. WHO Global tuberculosis report 2019 [Internet]. Genewa (Switzerland): World Health Organization; 2019 [cited 2019 Dec 20]. Available from http://www.who.int/tb/publications/global_report/en/WHO. WHO Global tuberculosis report 2019 [Internet]. Genewa (Switzerland): World Health Organization; 2019[cited 2019 Dec 20]. Available from http://www.who.int/tb/publications/global_report/en/Search in Google Scholar
Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, et al. Twenty years of global surveillance of antituberculosis-drug resistance. N Engl J Med. 2016 Sep 15;375(11):1081–1089. https://doi.org/10.1056/NEJMsr1512438ZignolMDeanASFalzonDvan GemertWWrightAvan DeunAPortaelsFLaszloAEspinalMAPablos-MéndezA, Twenty years of global surveillance of antituberculosis-drug resistance. N Engl J Med.2016Sep 15;375(11):1081–1089. https://doi.org/10.1056/NEJMsr151243810.1056/NEJMsr151243827626523Search in Google Scholar
Daniel TM. The history of tuberculosis. Respir Med. 2006 Nov; 100(11):1862–1870. https://doi.org/10.1016/j.rmed.2006.08.006DanielTM.The history of tuberculosis. Respir Med.2006Nov; 100(11):1862–1870. https://doi.org/10.1016/j.rmed.2006.08.00610.1016/j.rmed.2006.08.00616949809Search in Google Scholar